Clinical Trial Update: Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

This clinical trial update describes a phase 2 study comparing Gembrax followed by FOLFIRINOX versus FOLFIRINOX alone in patients with metastatic pancreatic can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FOLFIRINOX
• Gembrax

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: RECRUITING